Please login to the form below

Not currently logged in
Email:
Password:

Phagenesis

This page shows the latest Phagenesis news and features for those working in and with pharma, biotech and healthcare.

Nestlé Health Science invests $145m in food allergy biotech

Nestlé Health Science invests $145m in food allergy biotech

These include Nestlé's $1.9bn partnership on potential inflammatory bowel disease treatments and the acquisition of UK medical device firm and dysphagia specialist Phagenesis..

Latest news

  • Nestlé Health Science buys medical device firm Nestlé Health Science buys medical device firm

    Nestlé Health Science buys medical device firm. Acquisition of UK's Phagenesis expected to be completed by 2019. ... Nestlé Health Science is continuing to expand its interests in the broader pharma space with the acquisition of UK medical device firm

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
M&F Health

M&F Health is a full service communications agency, dedicated to the health and wellbeing sector. We are an independent amongst...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics